Portfolio (Quarterly)
Guide ↗
Defilade Capital Management, L.P.
· CIK 0002088557| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ZBH | ZIMMER BIOMET HOLDINGS INC | Healthcare | 579,161.0 | $52.4M | 7.35% | NEW | — | $90.42 | -5.8% |
| 2 | HSIC | SCHEIN HENRY INC | Healthcare | 624,037.0 | $46.0M | 6.46% | +304K | +94.8% | $73.70 | -1.4% |
| 3 | BDX | BECTON DICKINSON & CO | Healthcare | 279,210.0 | $43.9M | 6.16% | +198K | +243.8% | $157.23 | -6.5% |
| 4 | PTCT | PTC THERAPEUTICS INC | Healthcare | 376,165.0 | $41.1M | 5.77% | NEW | — | $109.29 | -35.8% |
| 5 | DXCM | DEXCOM INC | Healthcare | 538,762.0 | $33.8M | 4.75% | +294K | +120.0% | $62.80 | +3.6% |
| 6 | ICUI | ICU MED INC | Healthcare | 254,291.0 | $32.8M | 4.61% | -86K | -25.4% | $129.15 | -4.7% |
| 7 | INSM | INSMED INC | Healthcare | 194,909.0 | $31.9M | 4.47% | +145K | +289.8% | $163.52 | -34.5% |
| 8 | ISRG | INTUITIVE SURGICAL INC | Healthcare | 67,681.0 | $31.2M | 4.38% | +22K | +48.2% | $460.99 | -4.6% |
| 9 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 315,972.0 | $30.7M | 4.32% | -47K | -13.1% | $97.25 | +48.5% |
| 10 | — | GLOBUS MED INC | — | 354,350.0 | $30.5M | 4.29% | +87K | +32.6% | $86.16 | — |
| 11 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 209,932.0 | $27.7M | 3.88% | NEW | — | $131.74 | +19.3% |
| 12 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 1,359,969.0 | $26.1M | 3.67% | +703K | +107.1% | $19.20 | -4.2% |
| 13 | PACS | PACS GROUP INC | Financial Services | 604,180.0 | $25.6M | 3.60% | -541K | -47.3% | $42.42 | -13.2% |
| 14 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 1,504,536.0 | $22.4M | 3.15% | +270K | +21.9% | $14.91 | -13.5% |
| 15 | ELAN | ELANCO ANIMAL HEALTH INC | Healthcare | 931,121.0 | $22.3M | 3.13% | +530K | +132.0% | $23.93 | -16.7% |
| 16 | PFE | PFIZER INC | Healthcare | 1,464,129.0 | $19.4M | 2.73% | -739K | -33.5% | $13.25 | +91.1% |
| 17 | LLY | ELI LILLY & CO | Healthcare | 20,696.0 | $19.0M | 2.67% | -11K | -35.2% | $919.77 | +7.4% |
| 18 | LNTH | LANTHEUS HLDGS INC | Healthcare | 249,401.0 | $18.9M | 2.66% | NEW | — | $75.85 | +22.8% |
| 19 | ITGR | INTEGER HLDGS CORP | Healthcare | 213,027.0 | $18.7M | 2.63% | NEW | — | $88.00 | +2.2% |
| 20 | BIIB | BIOGEN INC | Healthcare | 96,289.0 | $17.7M | 2.48% | -66K | -40.6% | $183.33 | +3.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
96.2%
Financial Services
3.8%